TK-642 Long-Term Administration Study
Phase 3
- Conditions
- ncontrollable cancer pain
- Registration Number
- JPRN-jRCT2080221269
- Lead Sponsor
- TEIKOKU SEIYAKU CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1)Patients who were successful in titration of TK-642 in TK-642 Phase 2 Study
2)Patients who can give informed consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method